Skip to main content
Select Search Option
Menu
Weill Cornell Medicine
  • Weill Cornell Medicine
  • Care
  • Discover
  • Teach
Richard T. Silver MD Myeloproliferative Neoplasms Center
Richard T. Silver MD Myeloproliferative Neoplasms Center
Explore this Website
  • Home
  • For Patients
    • Conditions
      • Chronic Myeloid Leukemia
      • Essential Thrombocythemia
      • Myelofibrosis
      • Polycythemia Vera
      • Chronic Eosinophilic Leukemias
      • MDS/MPN
      • MPN-Unclassifiable
      • Mastocytosis
    • Complications
      • Bleeding
      • Cardiovascular Disease (heart failure, pulmonary artery hypertension)
      • Depression and other mood disorders
      • Diarrhea and other gastrointestinal complications
      • Pregnancy and MPNs
      • Pruritus (Itching)
      • Thrombosis/Blood Clots
      • Sexual Dysfunction
    • Treatments
      • Anagrelide (Agrylin®)
      • Anti-Coagulants
      • Aspirin
      • Bone Marrow Transplant
      • Bosutinib (Bosulif®)
      • Clopidogrel (Plavix®)
      • DNA Hypomethylating Agents (DHAs)
      • Dasatinib (Sprycel®)
      • Erythropoiesis-Stimulating Agents (ESAs)
      • Hydroxyurea
      • Imatinib (Gleevec®)
      • Interferons
      • Lenalidomide (Revlimid®)
      • Nilotinib (Tasigna®)
      • Phosphorous-32
      • Ponatinib (Iclusig®)
      • Prednisone
      • Ruxolitnib
      • Tyrosine Kinase Inhibitors (TKIs)
    • Frequently Asked Questions
    • Resources
    • Your First Visit
    • Request an Appointment
  • For Professionals
    • Refer a Patient
    • Featured Publications
    • Treatment Guidelines and Recommendations
      • Essential Thrombocythemia (ET)
  • News and Updates
    • Events
  • Research and Clinical Trials
    • Open MPN Clinical Trials
    • Our Research
  • About Us
    • Our Approach
    • Our Team
    • Leadership
    • Make a Difference
    • Directions
  • Weill Cornell Medicine
  • Care
  • Discover
  • Teach
  • Home
  • For Patients
  • For Professionals
  • News and Updates
  • Research and Clinical Trials
  • About Us
  • Home
  • Research and Clinical Trials
    • Open MPN Clinical Trials
    • Our Research

Research and Clinical Trials

The pursuit of basic, translational and clinical research is critical to moving the medical field forward and curing myeloproliferative neoplasms (MPNs). Learn more about laboratory research projects, clinical research initiatives and open clinical trials at the Richard T. Silver MD Myeloproliferative Neoplasms Center.

Clinical Trials

Clinical trials are vital to research, discovery, and patient care at the Silver MPN Center at Weill Cornell Medicine and NewYork-Presbyterian. Learn more about our open clinical trials for people with myeloproliferative neoplasms (MPNs).

Our Research

Physicians and scientists at the Silver MPN Center are dedicated to finding cures for myeloproliferative neoplasms through innovative lab-based research efforts.

Make a Difference

The Silver MPN Center provides cutting-edge care to patients while advancing the science to develop cures. This is made possible thanks to the support of generous donors and partners who share our mission and patients who participate in clinical trials to move the field forward. Help make a difference today!

(646) 962-2727
Request an Appointment Medical Records Make a Difference Email List

Richard T. Silver MD Myeloproliferative Neoplasms Center 520 E 70th Street Starr Pavillion, 341 New York, NY 10021 SilverMPNCenter@med.cornell.edu

Jump To Top
Our Location
Richard T. Silver MD Myeloproliferative Neoplasms Center
Contact Us
  • Twitter
  • Facebook
  • YouTube
520 E 70th Street Starr Pavillion, 341
New York, NY 10021
Phone: (646) 962-2727
Fax: (646) 962-0115
  • For Patients
    • Conditions
      • Chronic Myeloid Leukemia
      • Essential Thrombocythemia
      • Myelofibrosis
      • Polycythemia Vera
      • Chronic Eosinophilic Leukemias
      • MDS/MPN
      • MPN-Unclassifiable
      • Mastocytosis
    • Complications
      • Bleeding
      • Cardiovascular Disease (heart failure, pulmonary artery hypertension)
      • Depression and other mood disorders
      • Diarrhea and other gastrointestinal complications
      • Pregnancy and MPNs
      • Pruritus (Itching)
      • Thrombosis/Blood Clots
      • Sexual Dysfunction
    • Treatments
      • Anagrelide (Agrylin®)
      • Anti-Coagulants
      • Aspirin
      • Bone Marrow Transplant
      • Bosutinib (Bosulif®)
      • Clopidogrel (Plavix®)
      • DNA Hypomethylating Agents (DHAs)
      • Dasatinib (Sprycel®)
      • Erythropoiesis-Stimulating Agents (ESAs)
      • Hydroxyurea
      • Imatinib (Gleevec®)
      • Interferons
      • Lenalidomide (Revlimid®)
      • Nilotinib (Tasigna®)
      • Phosphorous-32
      • Ponatinib (Iclusig®)
      • Prednisone
      • Ruxolitnib
      • Tyrosine Kinase Inhibitors (TKIs)
    • Frequently Asked Questions
    • Resources
    • Your First Visit
    • Request an Appointment
  • For Professionals
    • Refer a Patient
    • Featured Publications
    • Treatment Guidelines and Recommendations
      • Essential Thrombocythemia (ET)
  • News and Updates
    • Events
  • Research and Clinical Trials
    • Open MPN Clinical Trials
    • Our Research
  • About Us
    • Our Approach
    • Our Team
    • Leadership
    • Make a Difference
    • Directions
Care. Discover. Teach. With a legacy of putting patients first, Weill Cornell Medicine is committed to providing exemplary and individualized clinical care, making groundbreaking biomedical discoveries, and educating generations of exceptional doctors and scientists.
Weill Cornell Medicine NewYork - Presbyterian
© Weill Cornell Medicine.
  • Privacy & Legal
  • Careers
  • Giving
  • Directory
  • Web Accessibility Assistance